Chronic Obstructive Pulmonary Disease (COPD) is the 4th leading cause of death in the U.S. (following Heart disease, Cancer and Stroke). COPD causes serious, long-term disability.
COPD kills more than 120,000 Americans each year. That’s one death every 4 minutes.
More than 12 million people are diagnosed with COPD.
An additional 12 million likely have COPD and don’t even know it.
Welcome at “www.copd.com”!
No Smoking Day is an annual health awareness campaign that helps smokers that want to stop. The first No Smoking Day was on Ash Wednesday in 1984 and it now takes place on the second Wednesday in March. Read the rest of this entry »
The National Institute for Health and Clinical Excellence (NICE) has today issued advice on the best way to encourage people to give up smoking. This is the first fully comprehensive guidance on smoking cessation issued by NICE to ensure that stop smoking services are as effective as possible.
The guidance is aimed at all professionals who have a direct or indirect role in helping people to quit smoking including PCTs, local authorities and community and voluntary sectors.
Smoking is estimated to cost the NHS £1.5 billion a year and remains the main cause of preventable morbidity and premature death in England. A wide range of diseases and conditions are caused by cigarette smoking, including cancers, respiratory diseases, coronary heart and other circulatory diseases. It is also the primary reason for the gap in healthy life expectancy between rich and poor. Read the rest of this entry »
Products should not be used in children under 2 years of age; evaluation continues in older populations Read the rest of this entry »
The Prevention of Chronic Obstructive Pulmonary Disease Exacerbations by Salmeterol/Fluticasone Propionate or Tiotropium Bromide
The study shows no difference in reduction of exacerbations between salmeterol/fluticasone propionate* and tiotropium**, although patients receiving the salmeterol/fluticasone combination were less likely to withdraw, had better health status, and had better survival.
*Advair® / Seretide® / Viani®, **Spiriva®
The U.S. Food and Drug Administration has approved tablet, chewable tablet, and syrup formulations of Zyrtec (cetirizine HCl) for nonprescription use. The nonprescription drug is approved for the temporary relief of symptoms due to hay fever or other respiratory allergies (sneezing; runny nose; itchy, watery eyes; itchy throat or nose) in adults and children 2 years of age and older. Read the rest of this entry »
Better understanding the influence of cigarette smoking and indoor air pollution on chronic obstructive pulmonary disease: A case–control study in Mainland China Read the rest of this entry »
Statement from Elizabeth G. Nabel, M.D., Director, National Heart, Lung, and Blood Institute, National Institutes of Health, on COPD Awareness Month, November 2007
COPD (chronic obstructive pulmonary disease), a serious lung disease, is the fourth leading cause of death in the United States. An American dies every 4.5 minutes from COPD. While there are 12 million people with a diagnosis of COPD, there may be another 12 million who have it and don’t know it. Read the rest of this entry »
American College of Physicians Issues Comprehensive Guidelines for Diagnosis and Treatment of Stable Chronic Obstructive Pulmonary Disease
Long-acting inhaled therapies, supplemental oxygen, and pulmonary rehabilitation are beneficial for patients with COPD. Read the rest of this entry »
The authors conducted a case-control survey nested within a birth cohort and collected detailed risk factor information to assess the extent to which residual confounding and exposure misclassification may impact air pollution effect estimates. Read the rest of this entry »